Refine
Document Type
- Article (5)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- histology (5) (remove)
Institute
Der Buchenspringrüssler Rhynchaenus fagi L. (Coleoptera: Curculionidae) ist ein 2 bis 3 mm großer, schwarz bis schwarzbraun gefärbter, fein grau behaarter Käfer. Ein besonderes Merkmal der Tiere sind die stark verdickten Hinterbeine, wodurch sie über das namensgebende große Sprungvermögen verfügen. Des Weiteren zeichnet er sich durch ein gutes Flugvermögen aus. R. fagi überwintert in der Bodenstreu bzw. in Rindenritzen. Die Imagines erscheinen im April/Mai und führen zunächst einen charakteristischen Lochfraß an Buchenblättern durch. Befressen werden dabei alle Altersstufen vom Sämling bis zum Altholz. Im Mai legen die Weibchen 30 bis 35 Eier einzeln in die Mittelrippe an der Unterseite von Blättern ab. Die Altkäfer sterben Anfang Juni. Die Larve erzeugt durch endophytischen Fraß zunächst eine Gangmine, welche sich in der Peripherie des Blattes zur Platzmine erweitert. Die Verpuppung findet nach 2- bis 3-wöchigem Fraß innerhalb der Platzmine in einem Kokon statt. Nach 10 Tagen bis 3 Wochen Puppenruhe schlüpfen ab Mitte Juni Jungkäfer, die bis zum Herbst an Blättern, Blattstielen und Fruchtansätzen der Buche fressen (SCHWERDTFEGER 1981). Vor allem bei Massenvermehrung verursachen Käfer und Larven durch ihren Fraß Zuwachsverluste sowie teilweise erhebliche Einbußen an der Bucheckernmast (ESCHERICH 1923). Neben Buche können sich adulte R. fagi auch von den Blättern zahlreicher anderer Baumarten (Erle, Birke, Obstbäume, etc.) ernähren, die Larvalentwicklung ist jedoch nur an Fagus-Arten möglich. Der Buchenspringrüssler ist im gesamten europäischen Raum verbreitet (SCHWENKE 1974). In Abhängigkeit von der Position in der Krone weisen Buchenblätter eine unterschiedliche Blattanatomie auf. Lichtblätter besitzen ein dickeres Schwammparenchym und insbesondere ein mehrschichtiges Palisadenparenchym. Letzteres ist in Schattenblätter einschichtig (SCHÜTT et al. 1992). Licht- undSchattenblätter unterscheiden sich auch in ihren Inhaltsstoffen. So konzentrieren sich aufgrund der höheren Photosyntheseleistung Kohlenhydrate und phenolische Substanzen in Blättern der Lichtkrone und vermindern sich tendenziell Stickstoffverbindungen (JOHNSON et al. 1997, YAMASAKI & KIKUZAWA 2003). Diese physiologischen Bedingungen können die Verwertbarkeit der Blätter für Insekten herabsetzen.
In gastric cancer (GC), there are four molecular subclasses that indicate whether patients respond to chemotherapy or immunotherapy, according to the TCGA. In clinical practice, however, not every patient undergoes molecular testing. Many laboratories have used well-implemented in situ techniques (IHC and EBER-ISH) to determine the subclasses in their cohorts. Although multiple stains are used, we show that a staining approach is unable to correctly discriminate all subclasses. As an alternative, we trained an ensemble convolutional neuronal network using bagging that can predict the molecular subclass directly from hematoxylin–eosin histology. We also identified patients with predicted intra-tumoral heterogeneity or with features from multiple subclasses, which challenges the postulated TCGA-based decision tree for GC subtyping. In the future, deep learning may enable targeted testing for molecular subtypes and targeted therapy for a broader group of GC patients. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
The permeability and inflammatory tissue reaction to Mucomaix® matrix (MM), a non- cross-linked collagen-based matrix was evaluated in both ex vivo and in vivo settings. Liquid platelet rich fibrin (PRF), a blood concentrate system, was used to assess its capacity to absorb human proteins and interact with blood cells ex vivo. In the in vivo aspect, 12 Wister rats had MM implanted subcutaneously, whereas another 12 rats (control) were sham-operated without biomaterial implantation. On days 3, 15 and 30, explantation was completed (four rats per time-point) to evaluate the tissue reactions to the matrix. Data collected were statistically analyzed using analysis of variance (ANOVA) and Tukey multiple comparisons tests (GraphPad Prism 8). The matrix absorbed the liquid PRF in the ex vivo study. Day 3 post-implantation revealed mild tissue inflammatory reaction with presence of mononuclear cells in the implantation site and on the biomaterial surface (mostly CD68-positive macrophages). The control group at this stage had more mononuclear cells than the test group. From day 15, multinucleated giant cells (MNGCs) were seen in the implantation site and the outer third of the matrix with marked increase on day 30 and spread to the matrix core. The presence of these CD68-positive MNGCs was associated with significant matrix vascularization. The matrix degraded significantly over the study period, but its core was still visible as of day 30 post-implantation. The high permeability and fast degradation properties of MM were highlighted.
The proliferative stimulus of the epidermal growth factor (EGF) in human epithelial cells is mediated by its binding to the external domain of the EGF receptor (EGF-R). The purpose of this study was to investigate whether growth arrest of tumors treated with anti-EGFR MAb (EMD 55900) was dependent on EGF-R expression and distinct histopathologic criteria of those neoplasms. Nine different adenocarcinomas, squamous cell carcinomas and two neoplastic epithelial cell lines (A431 and Detroit 562), which were characterized by high EGF-R expression, were xenotransplanted onto NMRI-nu/nu mice and treated with an anti-EGF-R antibody (EMD 55900). Results revealed that EGF-R expression and distinct histopathologic growth patterns play an important role for the therapeutic effect of the EGF-R antibody treatment. Tumors with high epithelial cellularity and little connective tissue responded to EMD 55900 treatment to a greater degree of growth reduction than tumors with lower cellularity. These results will be helpful for evaluation of patients who would benefit from tumor therapy with anti-EGF-R antibody.
Objective: To evaluate prognostic factors in pediatric patients with gonadal germ cell tumors (GCT). Methods: Patients <18 years with ovarian and testicular GCT (respectively OGCT and TGCT) were prospectively registered according to the guidelines of MAKEI 96. After resection of the primary tumor, patients staged ≥II received risk-stratified cisplatin-based combination chemotherapy. Patients were analyzed in respect to age (six age groups divided into 3-year intervals), histology, stage, and therapy. The primary end point was overall survival. Results: Between January 1996 and March 2016, the following patients were registered: 1047 OGCT, of those, 630 had ovarian teratoma (OTER) and 417 had malignant OGCT (MOGCT); and 418 TGCT, of those, 106 had testicular teratoma (TTER) and 312 had malignant TGCT (MTGCT). Only in MTGCT, older age correlated with a higher proportion of advanced tumors. All 736 teratomas and 240/415 stage I malignant gonadal GCT underwent surgery and close observation alone. In case of watchful waiting, the progression rate of OGCT was higher than that of TGCT. However, death from disease was reported in 8/417 (1.9%) MOGCT and 8/312 (2.6%) MTGCT irrespective of adjuvant chemotherapy and repeated surgery. Conclusions: The different pathogenesis and histogenesis of gonadal GCT reflects sex- and age-specific patterns that define clinically relevant risk groups. Therefore, gender and age should be considered in further research on the biology and clinical practice of pediatric gonadal GCT.